Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Kirurgisk Klinik i Helsinge ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7%   Bankruptcy risk   0.0% 9.3% 10.7% 6.9% 7.4% 6.3% 17.3% 17.3%   Credit score (0-100)   0 26 21 34 32 37 9 9   Credit rating   N/A BB BB BBB BB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   0.0 444 596 391 630 758 0.0 0.0   EBITDA   0.0 97.8 392 66.6 167 205 0.0 0.0   EBIT   0.0 82.4 360 34.1 135 134 0.0 0.0   Pre-tax profit (PTP)   0.0 83.5 350.0 30.4 137.4 130.2 0.0 0.0   Net earnings   0.0 61.7 269.2 21.3 104.2 98.4 0.0 0.0   Pre-tax profit without non-rec. items   0.0 83.5 350 30.4 137 130 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 30.7 123 90.6 205 134 0.0 0.0   Shareholders equity total   0.0 196 352 314 318 316 176 176   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0.0 325 487 373 419 433 176 176   Net Debt   0.0 -113 -217 -104 -80.8 -138 -176 -176     See the entire balance sheet 1000.0 Volume  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 444 596 391 630 758 0.0 0.0   Gross profit growth   0.0% 0.0% 34.1% -34.3% 61.0% 20.3% -100.0% 0.0%   Employees   0 0 1 1 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% -20.0% -62.5% 33.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 325 487 373 419 433 176 176   Balance sheet change%   0.0% 0.0% 50.1% -23.5% 12.5% 3.3% -59.4% 0.0%   Added value   0.0 97.8 392.3 66.6 167.6 205.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 15 60 -65 83 -142 -134 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   0.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   1000.0 Profitability  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 18.6% 60.4% 8.7% 21.4% 17.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.0% 26.1% 88.7% 7.9% 34.5% 31.7% 0.0% 0.0%   ROI %   0.0% 43.2% 131.3% 10.2% 42.9% 42.2% 0.0% 0.0%   ROE %   0.0% 31.5% 98.2% 6.4% 33.0% 31.0% 0.0% 0.0%   1000.0 Solidity  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   0.0% 60.3% 72.3% 84.1% 75.8% 73.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% -115.9% -55.2% -156.1% -48.4% -67.5% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.0 2.0 2.4 4.2 1.9 2.2 0.0 0.0   Current Ratio   0.0 2.0 2.4 4.2 1.9 2.2 0.0 0.0   Cash and cash equivalent   0.0 113.4 216.5 103.9 80.8 138.5 0.0 0.0   1000.0 Capital use efficiency  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 129.2 193.7 187.0 82.5 145.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 392 83 559 512 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 392 83 557 512 0 0   EBIT / employee   0 0 360 43 450 335 0 0   Net earnings / employee   0 0 269 27 347 246 0 0